Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2014

01-03-2014 | Review Article

Thyroid dysfunction in children with Down syndrome: a literature review

Authors: K. King, C. O’Gorman, S. Gallagher

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2014

Login to get access

Abstract

Introduction

This article is an evidence-based review of thyroid disease in children with Down syndrome, including a comparison between various professional guidelines for the management of thyroid disease in children with Down syndrome. Aspects of thyroid disease which are discussed include: congenital hypothyroidism; autoimmune thyroid disease; subclinical hypothyroidism; and hyperthyroidism. The national professional guidelines of Ireland, the United Kingdom, the United States of America, Australia and Canada are reviewed and compared.

Materials and methods

A literature search was conducted using Medline and PubMed. Search terms included ‘Down syndrome’ and ‘thyroid disease’, ‘hypothyroidism’, ‘hyperthyroidism’, ‘subclinical hypothyroidism’.

Results

Eighty-nine articles were retrieved and reviewed for inclusion. The guidelines on the medical management of children with Down syndrome of five expert groups have also been retrieved and reviewed for this discussion. These various guidelines offer largely similar advice regarding frequency of thyroid function tests, with only Ireland and the UK testing less frequently than annually. Only the United Kingdom and Irish Down Syndrome Medical Interest Group guidelines suggest testing for thyroid antibodies at every thyroid screen. None of the guidelines offer suggestions on the optimal course of action to pursue after the discovery of subclinical hypothyroidism.

Conclusion

In conclusion, more evidence is required regarding the optimal course of treatment for subclinical hypothyroidism. Such evidence may be best obtained by conducting a prospective randomized control trial.
Literature
1.
go back to reference Prasher VP (1999) Down syndrome and thyroid disorders—a review. Downs Syndr Res Pract 6(1):25–42PubMedCrossRef Prasher VP (1999) Down syndrome and thyroid disorders—a review. Downs Syndr Res Pract 6(1):25–42PubMedCrossRef
2.
go back to reference Tuysuz B, Beker DB (2001) Thyroid dysfunction in children with Down’s syndrome. Acta Paediatr 90(12):1389–1393PubMedCrossRef Tuysuz B, Beker DB (2001) Thyroid dysfunction in children with Down’s syndrome. Acta Paediatr 90(12):1389–1393PubMedCrossRef
3.
go back to reference Sharav T, Collins RM, Baab PJ (1988) Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302–1306PubMed Sharav T, Collins RM, Baab PJ (1988) Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302–1306PubMed
4.
go back to reference Fort P, Lifshitz F, Bellisario R et al (1984) Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 104:545–549PubMedCrossRef Fort P, Lifshitz F, Bellisario R et al (1984) Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 104:545–549PubMedCrossRef
5.
go back to reference Pascanu I, Banescu C, Benedek T et al (2009) Thyroid dysfunction in children with Down’s Syndrome. Acta Endocrinol (Bucharest, Rom.) 5(1):85–92CrossRef Pascanu I, Banescu C, Benedek T et al (2009) Thyroid dysfunction in children with Down’s Syndrome. Acta Endocrinol (Bucharest, Rom.) 5(1):85–92CrossRef
6.
go back to reference Cutler AT, Benezra-Obeiter R, Brink SJ (1986) Thyroid function in young children with Down syndrome. Am J Dis Child 140:479–483PubMed Cutler AT, Benezra-Obeiter R, Brink SJ (1986) Thyroid function in young children with Down syndrome. Am J Dis Child 140:479–483PubMed
7.
go back to reference Unachak K, Tanpaiboon P, Pongprot Y et al (2008) Thyroid functions in children with Down’s syndrome. J Med Assoc Thailand 91(1):56–61 Unachak K, Tanpaiboon P, Pongprot Y et al (2008) Thyroid functions in children with Down’s syndrome. J Med Assoc Thailand 91(1):56–61
8.
go back to reference Van Trotsenburg ASP, Vulsma T, van Santen HM et al (2003) Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88(4):1512–1515PubMedCrossRef Van Trotsenburg ASP, Vulsma T, van Santen HM et al (2003) Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88(4):1512–1515PubMedCrossRef
9.
go back to reference Van Trotsenburg AS, Vulsma T, Rozenburg-Marres SL (2005) The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90(6):3304–3311PubMedCrossRef Van Trotsenburg AS, Vulsma T, Rozenburg-Marres SL (2005) The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90(6):3304–3311PubMedCrossRef
10.
go back to reference Karlsson B, Gustafsson J, Hedov G et al (1998) Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79(3):242–245PubMedCrossRef Karlsson B, Gustafsson J, Hedov G et al (1998) Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79(3):242–245PubMedCrossRef
11.
go back to reference Loudon MM, Day RE, Duke EMC (1985) Thyroid dysfunction in Down’s syndrome. Arch Dis Child 60:1149–1151PubMedCrossRef Loudon MM, Day RE, Duke EMC (1985) Thyroid dysfunction in Down’s syndrome. Arch Dis Child 60:1149–1151PubMedCrossRef
12.
go back to reference Ivarsson SA, Ericsson UB, Gustafsson J et al (1997) The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 86(10):1065–1067PubMedCrossRef Ivarsson SA, Ericsson UB, Gustafsson J et al (1997) The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 86(10):1065–1067PubMedCrossRef
13.
go back to reference Rashid N, Mumtaz A, Mehmood S et al (2009) Assessment of thyroid dysfunction in Down syndrome patients. Pak Paediatr J 33(4):211–217 Rashid N, Mumtaz A, Mehmood S et al (2009) Assessment of thyroid dysfunction in Down syndrome patients. Pak Paediatr J 33(4):211–217
14.
go back to reference Noble SE, Leyland K, Findlay CA et al (2000) School based screening for hypothyroidism in Down’s syndrome by dried blood spot TSH measurement. Arch Dis Child 82:27–31PubMedCrossRef Noble SE, Leyland K, Findlay CA et al (2000) School based screening for hypothyroidism in Down’s syndrome by dried blood spot TSH measurement. Arch Dis Child 82:27–31PubMedCrossRef
15.
go back to reference Friedman D, Kastner T, Pond W et al (1989) Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med 149:1990–1993PubMedCrossRef Friedman D, Kastner T, Pond W et al (1989) Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med 149:1990–1993PubMedCrossRef
17.
go back to reference Caraccio N, Dardano A, Manfredonia F (2005) Longterm follow-up of 106 multiple sclerosis patients undergoing interferon-{beta} 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90(7):4133–4137PubMedCrossRef Caraccio N, Dardano A, Manfredonia F (2005) Longterm follow-up of 106 multiple sclerosis patients undergoing interferon-{beta} 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90(7):4133–4137PubMedCrossRef
18.
go back to reference Gibson PA, Newton RW, Selby K et al (2005) Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Child 90:574–578PubMedCrossRef Gibson PA, Newton RW, Selby K et al (2005) Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Child 90:574–578PubMedCrossRef
19.
go back to reference Rubello D, Pozzan GB, Casara D et al (1995) Natural Course of subclinical hypothyroidism in Down’s syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 18:35–40PubMed Rubello D, Pozzan GB, Casara D et al (1995) Natural Course of subclinical hypothyroidism in Down’s syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 18:35–40PubMed
20.
go back to reference Faria C, Ribeiro S, Kochi C et al (2011) TSH neurosecretory dysfunction (TSH-nd) in Down syndrome: low risk of progression to Hashimoto’s thyroiditis. Arq Bras Endocrinol Metabol. 55(8):628–631PubMedCrossRef Faria C, Ribeiro S, Kochi C et al (2011) TSH neurosecretory dysfunction (TSH-nd) in Down syndrome: low risk of progression to Hashimoto’s thyroiditis. Arq Bras Endocrinol Metabol. 55(8):628–631PubMedCrossRef
21.
go back to reference Prasher V, Ninan S, Haque S (2011) Fifteen-year follow-up of thyroid status in adults with Down syndrome. J Intellect Disabil Res 55(4):392–396PubMedCrossRef Prasher V, Ninan S, Haque S (2011) Fifteen-year follow-up of thyroid status in adults with Down syndrome. J Intellect Disabil Res 55(4):392–396PubMedCrossRef
22.
go back to reference Pueschel SM, Pezzullo JC (1985) Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636–639PubMed Pueschel SM, Pezzullo JC (1985) Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636–639PubMed
23.
go back to reference Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux J et al (2009) Hyperthyroidism in a population with Down syndrome. Clin Endocrinol 71:110–114CrossRef Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux J et al (2009) Hyperthyroidism in a population with Down syndrome. Clin Endocrinol 71:110–114CrossRef
24.
go back to reference Londhey VA, Rajadhyaksha GC, Barhate KS et al (2010) Hyperthyroidism in a case of Down Syndrome. J Assoc Physicians India 58:568–569PubMed Londhey VA, Rajadhyaksha GC, Barhate KS et al (2010) Hyperthyroidism in a case of Down Syndrome. J Assoc Physicians India 58:568–569PubMed
25.
go back to reference Medical management of children and adolescents with Down syndrome in Ireland. (2001)Down’s Syndrome Medical Interest Group (DSMIG) UK § Ireland Medical management of children and adolescents with Down syndrome in Ireland. (2001)Down’s Syndrome Medical Interest Group (DSMIG) UK § Ireland
26.
go back to reference Basic medical surveillance essentials for people with Down’s Syndrome-Thyroid Disorder. Down’s Syndrome Medical Interest Group (DSMIG) UK, 2001 Basic medical surveillance essentials for people with Down’s Syndrome-Thyroid Disorder. Down’s Syndrome Medical Interest Group (DSMIG) UK, 2001
27.
go back to reference American Academy of Pediatrics (2011) Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 128:393–406CrossRef American Academy of Pediatrics (2011) Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 128:393–406CrossRef
28.
go back to reference Tracy J (2011) Australians with Down syndrome-—Health matters. Aust Fam Physician 40(4):202–208PubMed Tracy J (2011) Australians with Down syndrome-—Health matters. Aust Fam Physician 40(4):202–208PubMed
29.
go back to reference Van Cleve S, Cohen W (2006) Part I: Clinical practice guidelines with Down Syndrome from birth to 12 years. J Pediatr Health Care 20(1):47–54PubMedCrossRef Van Cleve S, Cohen W (2006) Part I: Clinical practice guidelines with Down Syndrome from birth to 12 years. J Pediatr Health Care 20(1):47–54PubMedCrossRef
30.
go back to reference Van Cleve S, Cohen W (2006) Part II: Clinical practice guidelines for adolescents and young adults with Down syndrome: 12–21 years. J Pediatr Health Care 20(3):198–205PubMedCrossRef Van Cleve S, Cohen W (2006) Part II: Clinical practice guidelines for adolescents and young adults with Down syndrome: 12–21 years. J Pediatr Health Care 20(3):198–205PubMedCrossRef
Metadata
Title
Thyroid dysfunction in children with Down syndrome: a literature review
Authors
K. King
C. O’Gorman
S. Gallagher
Publication date
01-03-2014
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2014
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-013-0994-y

Other articles of this Issue 1/2014

Irish Journal of Medical Science (1971 -) 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.